The company is seeking submissions from researchers in various disciplines, including inter alia DNA synthesis, gene editing, gene therapy, mRNA vaccines and therapeutics, enzyme engineering, synthetic cells, xeno-nucleic acids, and CAR T cells, that aim to address challenges and unmet needs that are biomedical, environmental, or industrial.

After a three-step selection and training process, the Eurekawards will take place virtually on November 10, 2021. Finalists will pitch their projects to Eurekare's expert panel. The winner will receive free access to Eurekare's synthetic biology studio, Eurekasynbio, for one year. The award includes advice concerning strategy, equity financing, grants, communications, and more. The winner will also receive guidance and support from Eurekare's team and a network of academic and industrial professionals in synthetic biology.

Eurekare will accept applications through September 15. More information is available on the company's website.